BusinessTeva and Checkpoint Therapeutics Announce License Agreement for Oral PARP InhibitorBy Nasdaq OMXJan 7, 2016, 3:57 PM UTC
BusinessXeris Pharmaceuticals Announces $41 Million Series C FinancingBy Nasdaq OMXJan 7, 2016, 3:25 PM UTC
BusinessAdaptimmune Expands T-cell Engineering Expertise to Develop Affinity Enhanced T-cell Therapies for Autoimmune IndicationsBy Nasdaq OMXJan 7, 2016, 2:00 PM UTC
BusinessGenticel to Evaluate Roche Molecular Systems’ cobas® HPV Test in Preparation for Phase 3 Program of GTL001By Nasdaq OMXJan 7, 2016, 1:00 PM UTC
BusinessMyriad Advances Prostate and Renal Cancer Molecular Diagnostic Tests at the 2016 ASCO Genitourinary Cancers SymposiumBy Nasdaq OMXJan 7, 2016, 12:05 PM UTC
BusinessAGTC Announces Preclinical Data Evaluating Cone-Specific Promoters for Use in Gene Therapy of Achromatopsia and Other Retinal DiseasesBy Nasdaq OMXJan 7, 2016, 12:01 PM UTC
BusinessuniQure Announces Preliminary Topline Results from Low-Dose Cohort in Hemophilia B Phase I/II Gene Therapy Clinical TrialBy Nasdaq OMXJan 7, 2016, 11:00 AM UTC
BusinessCancer Genetics, Inc. (CGI) to Present Results of Collaborative Renal Biopsy and Clear Cell Renal Cell Carcinoma (ccRCC) Studies at the 2016 Genitourinary Cancer SymposiumBy Nasdaq OMXJan 6, 2016, 11:23 PM UTC
